Status:
RECRUITING
Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
Lallemand Health Solutions
Conditions:
Healthy Newborn Infants
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
The aim is to study whether the microbiota of children who are exposed to antibiotics at birth could be modified by synbiotic supplement and thereby reduce the risk of obesity, chronic diseases and re...
Eligibility Criteria
Inclusion
- Pregnant women (n=125) and their newborn children who receive antibiotic treatment at delivery.
Exclusion
- Chorioamnionitis
- Pre-eclampsia and hepatogestosis
- Suspected malformation or serious condition of the foetus and neonates
- Serious infection or other conditions not permitting breast milk feeding
Key Trial Info
Start Date :
May 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06974994
Start Date
May 8 2024
End Date
December 1 2029
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku
Turku, Valitse Maakunta., Finland, 20780